RxDoctor Payments Data

Arnaldo Perez, MD

Allergy & Immunology · San Juan, PRNPI 1306042908

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 35.9% of the total. That places this record below the midpoint for allergy & immunology clinicians in PR, where the typical reported total is $2,799.

$334in general payments, 2019–2025

Across 11 payments — averaging $30.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$120
  • GSK$63
  • Sanofi$63
  • Incyte Corporation$32
  • Grifols USA, LLC$16
  • ABC Home Medical Supply, Inc.$16
  • plus $24 from 2 others

What the payments were for

  • Food & beverage$334100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron Healthcare Solutions, Inc.1$120
GSK3$63
Sanofi2$63
Incyte Corporation1$32
Grifols USA, LLC1$16
ABC Home Medical Supply, Inc.1$16
CSL Behring1$12
Alk-abello, Inc1$12

How this compares

$334 in reported general payments places this provider in the 20th percentile of 25 allergy & immunology providers in Puerto Rico.

See all allergy & immunology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$31,618
Medicare patients
80
Services billed
1,663

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab30$123,032
XolairOmalizumab11$26,914
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$15,944
XhanceFluticasone Propionate11$6,498
SymbicortBudesonide/Formoterol Fumarate18$5,354
Wixela InhubFluticasone Propion/Salmeterol24$2,685
BreynaBudesonide/Formoterol Fumarate13$2,387
Azelastine Hcl63$1,842
Mometasone Furoate20$1,835
Ipratropium Bromide25$800
Montelukast Sodium37$778
Fluticasone Propionate45$759
Albuterol Sulfate HfaAlbuterol Sulfate27$586
Levocetirizine Dihydrochloride13$287
Prednisone11$37

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$63$15,94418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 25 allergy & immunology providers in Puerto Rico.

Other allergy & immunology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →